Arrowhead Pharmaceuticals, Inc. (ARWR)

66.47 +1.67 (+2.58%) USD  |  NASDAQ  |  Dec 18, 16:00
66.73 +0.26 (+0.39%) Pre-Market: 08:51
More

Arrowhead Pharmaceuticals Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly)

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade